* Requires refrigeration:@0.079566:0.900677:0.163296:0.900677:0.163296:0.890330:0.079566:0.890330:0.003168:0.002264:0.005880:0.004528:0.004528:0.004528:0.001808:0.002712:0.004528:0.004072:0.002264:0.002712:0.004528:0.002264:0.002712:0.001808:0.004528:0.004528:0.002712:0.004528:0.002264:0.001808:0.004528:0.004528
References: 1. :@0.079566:0.913815:0.138041:0.913815:0.138041:0.902978:0.079566:0.902978:0.005880:0.004528:0.002712:0.004528:0.003168:0.004528:0.004976:0.004528:0.004528:0.004528:0.002712:0.002802:0.004528:0.002264:0.002264
South African Glaucoma Society. Glaucoma algorithm and guidelines for glaucoma. c2016. Accessed 29 Nov 2018. Available from URL: http://docs.wixstatic.:@0.138579:0.913418:0.711966:0.913418:0.711966:0.903071:0.138579:0.903071:0.005432:0.004528:0.004528:0.002264:0.004528:0.002354:0.005432:0.002264:0.002712:0.001808:0.004072:0.004528:0.004528:0.002802:0.006336:0.001808:0.004528:0.004528:0.004072:0.004528:0.006784:0.004528:0.002802:0.005432:0.004528:0.004072:0.001808:0.004528:0.002264:0.003469:0.002264:0.002802:0.006336:0.001808:0.004528:0.004528:0.004072:0.004528:0.006784:0.004528:0.002802:0.004528:0.001808:0.004528:0.004528:0.002712:0.001808:0.002264:0.004528:0.006784:0.002802:0.004528:0.004528:0.004528:0.002802:0.004528:0.004528:0.001808:0.004528:0.004528:0.001808:0.001808:0.004528:0.004528:0.004072:0.002802:0.002264:0.004528:0.002712:0.002802:0.004528:0.001808:0.004528:0.004528:0.004072:0.004528:0.006784:0.004528:0.002264:0.002802:0.004072:0.004528:0.004528:0.004528:0.004528:0.002264:0.002354:0.005432:0.004072:0.004072:0.004528:0.004072:0.004072:0.004528:0.004528:0.002802:0.004528:0.004528:0.002802:0.005880:0.004528:0.004072:0.002802:0.004528:0.004528:0.004528:0.004528:0.002264:0.002354:0.005286:0.004072:0.004528:0.001808:0.001808:0.004528:0.004528:0.001808:0.004528:0.002802:0.002264:0.002712:0.004528:0.006784:0.002802:0.005880:0.005880:0.004528:0.002264:0.002802:0.004528:0.002264:0.002264:0.004528:0.002264:0.002264:0.002264:0.004528:0.004528:0.004072:0.004072:0.002264:0.005880:0.001808:0.004072:0.004072:0.002264:0.004528:0.002264:0.001808:0.004072:0.002264
com/ugd/280453_6b7e555101fe49c2ab599bbdf300993d.pdf   Denis P, Baudouin C, Bron A, :@0.079566:0.922490:0.417336:0.922490:0.417336:0.912143:0.079566:0.912143:0.004072:0.004528:0.006784:0.002264:0.004528:0.004528:0.004528:0.002264:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.002264:0.004528:0.004528:0.004528:0.004072:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.002264:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.002264:0.004528:0.004528:0.002264:0.002264:0.006792:0.002215:0.005880:0.004528:0.004528:0.001808:0.004072:0.002215:0.004381:0.002264:0.002215:0.005432:0.004528:0.004528:0.004528:0.004528:0.004528:0.001808:0.004528:0.002215:0.005880:0.002264:0.002215:0.005432:0.002712:0.004528:0.004528:0.001767:0.005432:0.002264:0.002264
2.:@0.300525:0.922887:0.307317:0.922887:0.307317:0.912050:0.300525:0.912050:0.004528:0.002264
et al:@0.417287:0.922490:0.432630:0.922490:0.432630:0.912205:0.417287:0.912205:0.004528:0.002264:0.002215:0.004528:0.001808
. First-line latanoprost therapy in ocular hypertension or open-angle glaucoma :@0.432630:0.922490:0.714189:0.922490:0.714189:0.912143:0.432630:0.912143:0.002264:0.002215:0.004976:0.001808:0.002712:0.004072:0.002264:0.002712:0.001808:0.001808:0.004528:0.004528:0.002215:0.001808:0.004528:0.002264:0.004528:0.004528:0.004528:0.004528:0.002712:0.004528:0.004072:0.002264:0.002215:0.002264:0.004528:0.004528:0.002712:0.004528:0.004528:0.004072:0.002215:0.001808:0.004528:0.002215:0.004528:0.004072:0.004528:0.001808:0.004528:0.002712:0.002215:0.004528:0.004072:0.004528:0.004528:0.002712:0.002264:0.004528:0.004528:0.004072:0.001808:0.004528:0.004528:0.002215:0.004528:0.002712:0.002215:0.004528:0.004528:0.004528:0.004528:0.002712:0.004528:0.004528:0.004528:0.001808:0.004528:0.002215:0.004528:0.001808:0.004528:0.004528:0.004072:0.004528:0.006784:0.004528:0.002264
patients: a 3-month efficacy analysis stratified by initial intraocular pressure. :@0.079566:0.931563:0.361198:0.931563:0.361198:0.921215:0.079566:0.921215:0.004528:0.004528:0.002264:0.001808:0.004528:0.004528:0.002264:0.004072:0.002264:0.003030:0.004528:0.003030:0.004528:0.002712:0.006784:0.004528:0.004528:0.002264:0.004528:0.003030:0.004528:0.002264:0.002036:0.002036:0.004072:0.004528:0.004072:0.004072:0.003030:0.004528:0.004528:0.004528:0.001808:0.004072:0.004072:0.001808:0.004072:0.003030:0.004072:0.002264:0.002712:0.004528:0.002264:0.001808:0.002036:0.002036:0.004528:0.004528:0.003030:0.004528:0.004072:0.003030:0.001808:0.004528:0.001808:0.002264:0.001808:0.004528:0.001808:0.003030:0.001808:0.004528:0.002264:0.002712:0.004528:0.004528:0.004072:0.004528:0.001808:0.004528:0.002712:0.003030:0.004528:0.002712:0.004528:0.004072:0.004072:0.004528:0.002712:0.004528:0.002264:0.002264
BMC Ophthalmology:@0.361980:0.931563:0.437875:0.931563:0.437875:0.921278:0.361980:0.921278:0.005432:0.006784:0.005880:0.003030:0.006336:0.004528:0.004528:0.002264:0.004528:0.004528:0.001808:0.006784:0.004528:0.001808:0.004528:0.004528:0.004072
 2010; :4.   WHO Model List of Essential Medicines (March 2017). 20th :@0.437875:0.931563:0.714270:0.931563:0.714270:0.921215:0.437875:0.921215:0.003030:0.004528:0.004528:0.004528:0.004528:0.002264:0.009056:0.002264:0.004528:0.002264:0.002264:0.007566:0.003030:0.007688:0.005880:0.006336:0.003030:0.006784:0.004528:0.004528:0.004528:0.001808:0.003030:0.004528:0.001808:0.004072:0.002264:0.003030:0.004528:0.002264:0.003030:0.005432:0.004072:0.004072:0.004528:0.004528:0.002264:0.001808:0.004528:0.001808:0.003030:0.006784:0.004528:0.004528:0.001808:0.004072:0.001808:0.004528:0.004528:0.004072:0.003030:0.002712:0.006784:0.004528:0.002712:0.004072:0.004528:0.003030:0.004528:0.004528:0.004528:0.004528:0.002712:0.002264:0.003030:0.004528:0.004528:0.002264:0.004528:0.002264
10:@0.461281:0.931959:0.470338:0.931959:0.470338:0.921122:0.461281:0.921122:0.004528:0.004528
3.:@0.482432:0.931959:0.489224:0.931959:0.489224:0.921122:0.482432:0.921122:0.004528:0.002264
edition. Cited 2018 Nov 30. Available from URL: http://www.who.int/medicines/publications/essentialmedicines/20th_EML2017.pdf:@0.079566:0.940635:0.546102:0.940635:0.546102:0.930288:0.079566:0.930288:0.004528:0.004528:0.001808:0.002264:0.001808:0.004528:0.004528:0.002264:0.002264:0.005880:0.001808:0.002264:0.004528:0.004528:0.002264:0.004528:0.004528:0.004528:0.004528:0.002264:0.005880:0.004528:0.004072:0.002264:0.004528:0.004528:0.002264:0.001816:0.005286:0.004072:0.004528:0.001808:0.001808:0.004528:0.004528:0.001808:0.004528:0.002264:0.002264:0.002712:0.004528:0.006784:0.002264:0.005880:0.005880:0.004528:0.002264:0.002264:0.004528:0.002264:0.002264:0.004528:0.002264:0.002264:0.002264:0.005880:0.005880:0.005432:0.002264:0.005880:0.004528:0.004528:0.002264:0.001808:0.004528:0.002264:0.002264:0.006784:0.004528:0.004528:0.001808:0.004072:0.001808:0.004528:0.004528:0.004072:0.002264:0.004528:0.004528:0.004528:0.001808:0.001808:0.004072:0.004528:0.002264:0.001808:0.004528:0.004528:0.004072:0.002264:0.004528:0.004072:0.004072:0.004528:0.004528:0.002264:0.001808:0.004528:0.001808:0.006784:0.004528:0.004528:0.001808:0.004072:0.001808:0.004528:0.004528:0.004072:0.002264:0.004528:0.004528:0.002264:0.004528:0.004528:0.005432:0.006784:0.004528:0.004528:0.004528:0.004528:0.004528:0.002264:0.004528:0.004528:0.002264
S4:@0.080825:0.952130:0.088769:0.952130:0.088769:0.943877:0.080825:0.943877:0.004333:0.003612
 :@0.090028:0.953370:0.092292:0.953370:0.092292:0.943023:0.090028:0.943023:0.002264
Spersatan Eye Drop Solution:@0.092740:0.953767:0.206318:0.953767:0.206318:0.942930:0.092740:0.942930:0.005432:0.004976:0.004528:0.003168:0.004528:0.004528:0.002712:0.004528:0.004976:0.002712:0.005432:0.004528:0.004528:0.002712:0.005880:0.003168:0.004976:0.004976:0.002712:0.005432:0.004976:0.002264:0.004976:0.002712:0.002264:0.004976:0.004976
. Each 1 ml contains: Latanoprost 50 μg. Reg. No. 46/15.4/0918. Under license from Novartis Pharma AG, Hettlingen, Switzerland. For full :@0.206318:0.953370:0.714267:0.953370:0.714267:0.943023:0.206318:0.943023:0.002264:0.002712:0.005432:0.004528:0.004072:0.004528:0.002712:0.004528:0.002712:0.006784:0.001808:0.002712:0.004072:0.004528:0.004528:0.002264:0.004528:0.001808:0.004528:0.004072:0.002264:0.002712:0.004528:0.004528:0.002264:0.004528:0.004528:0.004528:0.004528:0.002712:0.004528:0.004072:0.002264:0.002712:0.004528:0.004528:0.002712:0.004691:0.004528:0.002264:0.002712:0.005880:0.004528:0.004528:0.002264:0.002712:0.005880:0.004528:0.002264:0.002712:0.004528:0.004528:0.002264:0.004528:0.004528:0.002264:0.004528:0.002264:0.004528:0.004528:0.004528:0.004528:0.002264:0.002712:0.005880:0.004528:0.004528:0.004528:0.002712:0.002712:0.001808:0.001808:0.004072:0.004528:0.004528:0.004072:0.004528:0.002712:0.002264:0.002712:0.004528:0.006784:0.002712:0.005880:0.004528:0.004072:0.004528:0.002712:0.002264:0.001808:0.004072:0.002712:0.005432:0.004528:0.004528:0.002712:0.006784:0.004528:0.002264:0.005432:0.006336:0.002264:0.002712:0.005880:0.004528:0.002264:0.002264:0.001808:0.001808:0.004528:0.004528:0.004528:0.004528:0.002264:0.002712:0.005432:0.005880:0.001808:0.002264:0.004072:0.004528:0.002712:0.001808:0.004528:0.004528:0.004528:0.002264:0.002712:0.004976:0.004528:0.002712:0.002712:0.002264:0.004528:0.001808:0.001808:0.002264
prescribing information refer to the package insert approved by the medicines regulatory authority. Adcock Ingram Limited. Reg. No. 1949/034385/06. Private Bag X69, Bryanston, :@0.079571:0.962442:0.714251:0.962442:0.714251:0.952095:0.079571:0.952095:0.004528:0.002712:0.004528:0.004072:0.004072:0.002712:0.001808:0.004528:0.001808:0.004528:0.004528:0.001840:0.001808:0.004528:0.002264:0.004528:0.002712:0.006784:0.004528:0.002264:0.001808:0.004528:0.004528:0.001840:0.002712:0.004528:0.002264:0.004528:0.002712:0.001840:0.002264:0.004528:0.001840:0.002264:0.004528:0.004528:0.001840:0.004528:0.004528:0.004072:0.004072:0.004528:0.004528:0.004528:0.001840:0.001808:0.004528:0.004072:0.004528:0.002712:0.002264:0.001840:0.004528:0.004528:0.004528:0.002712:0.004528:0.004072:0.004528:0.004528:0.001840:0.004528:0.004072:0.001840:0.002264:0.004528:0.004528:0.001840:0.006784:0.004528:0.004528:0.001808:0.004072:0.001808:0.004528:0.004528:0.004072:0.001840:0.002712:0.004528:0.004528:0.004528:0.001808:0.004528:0.002264:0.004528:0.002712:0.004072:0.001840:0.004528:0.004528:0.002264:0.004528:0.004528:0.002712:0.001808:0.002264:0.003469:0.002264:0.001393:0.005432:0.004528:0.004072:0.004528:0.004072:0.004072:0.001840:0.002264:0.004528:0.004528:0.002712:0.004528:0.006784:0.001840:0.004528:0.001808:0.006784:0.001808:0.002264:0.004528:0.004528:0.002264:0.001840:0.005880:0.004528:0.004528:0.002264:0.001840:0.005880:0.004528:0.002264:0.001840:0.004528:0.004528:0.004528:0.004528:0.002264:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.002264:0.004528:0.004528:0.002264:0.001840:0.005432:0.002712:0.001808:0.004072:0.004528:0.002264:0.004528:0.001840:0.005432:0.004528:0.004528:0.001840:0.005432:0.004528:0.004528:0.002264:0.001840:0.005432:0.002712:0.004072:0.004528:0.004528:0.004072:0.002264:0.004528:0.004528:0.002264:0.002264
2021, South Africa. Telephone + 27 11 635 0000. www.adcock.com. 2018121310113824:@0.079571:0.971514:0.397176:0.971514:0.397176:0.961167:0.079571:0.961167:0.004528:0.004528:0.004528:0.004528:0.002264:0.002264:0.005432:0.004528:0.004528:0.002264:0.004528:0.001816:0.005432:0.002264:0.002712:0.001808:0.004072:0.004528:0.002264:0.002118:0.004072:0.004528:0.001808:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.002264:0.004756:0.002264:0.004528:0.004528:0.002264:0.003925:0.004528:0.002264:0.004528:0.004528:0.004528:0.002264:0.004528:0.004528:0.004528:0.004528:0.002264:0.002264:0.005880:0.005880:0.005432:0.002264:0.004528:0.004528:0.004072:0.004528:0.004072:0.004072:0.002264:0.004072:0.004528:0.006784:0.002264:0.002264:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.004528:0.003925:0.004528:0.004528:0.004528:0.004528:0.004528
•:@0.218485:0.570153:0.236642:0.570153:0.236642:0.539039:0.218485:0.539039:0.018157
   A first-line option for :@0.236643:0.569139:0.564198:0.569139:0.564198:0.545315:0.236643:0.545315:0.007730:0.007730:0.007730:0.018519:0.007730:0.009273:0.009273:0.012346:0.013903:0.012346:0.010816:0.007730:0.007730:0.018547:0.016990:0.007730:0.018547:0.018547:0.012346:0.007730:0.018547:0.018547:0.007730:0.010816:0.018547:0.012346:0.007730
Glaucoma:@0.564193:0.569875:0.736056:0.569875:0.736056:0.540368:0.564193:0.540368:0.022668:0.009448:0.020765:0.022668:0.018896:0.022668:0.033985:0.020765
 :@0.736055:0.569139:0.743785:0.569139:0.743785:0.545315:0.736055:0.545315:0.007730
1:@0.743785:0.560687:0.752798:0.560687:0.752798:0.546798:0.743785:0.546798:0.009013
•:@0.218485:0.637031:0.236642:0.637031:0.236642:0.605917:0.218485:0.605917:0.018157
   :@0.236643:0.636017:0.259833:0.636017:0.259833:0.612193:0.236643:0.612193:0.007730:0.007730:0.007730
Lower incidence:@0.259833:0.636753:0.543098:0.636753:0.543098:0.607246:0.259833:0.607246:0.016993:0.022668:0.032082:0.020765:0.015089:0.009448:0.009448:0.022668:0.018896:0.009448:0.022668:0.020765:0.022668:0.018896:0.020765
 of hyperaemia than    :@0.543096:0.636017:0.856804:0.636017:0.856804:0.612193:0.543096:0.612193:0.007730:0.018547:0.010816:0.007730:0.018547:0.015460:0.018547:0.016990:0.012346:0.015460:0.016990:0.027806:0.007730:0.015460:0.007730:0.012346:0.018547:0.015460:0.018547:0.007730:0.007730:0.007730:0.007730
      bimatoprost and travaprost :@0.218488:0.665744:0.663497:0.665744:0.663497:0.641920:0.218488:0.641920:0.007730:0.007730:0.007730:0.007730:0.007730:0.007730:0.018547:0.007730:0.027806:0.015460:0.012346:0.018547:0.018547:0.012346:0.018547:0.013903:0.012346:0.007730:0.015460:0.018547:0.018547:0.007730:0.012346:0.012346:0.015460:0.015460:0.015460:0.018547:0.012346:0.018547:0.013903:0.012346:0.007730
2:@0.663488:0.657292:0.672501:0.657292:0.672501:0.643403:0.663488:0.643403:0.009013
•:@0.218485:0.740357:0.236642:0.740357:0.236642:0.709243:0.218485:0.709243:0.018157
   On the :@0.236643:0.739343:0.361798:0.739343:0.361798:0.715519:0.236643:0.715519:0.007730:0.007730:0.007730:0.020076:0.018547:0.007730:0.012346:0.018547:0.016990:0.007730
WHO essential drug list:@0.361796:0.740079:0.760203:0.740079:0.760203:0.710572:0.361796:0.710572:0.033985:0.024537:0.024537:0.009448:0.020765:0.016993:0.016993:0.020765:0.022668:0.015089:0.009448:0.020765:0.009448:0.009448:0.022668:0.015089:0.022668:0.022668:0.009448:0.009448:0.009448:0.016993:0.015089
  :@0.760199:0.739343:0.775660:0.739343:0.775660:0.715200:0.760199:0.715200:0.007730:0.007730
      :@0.218481:0.769070:0.264862:0.769070:0.264862:0.744928:0.218481:0.744928:0.007730:0.007730:0.007730:0.007730:0.007730:0.007730
for Glaucoma :@0.264862:0.769070:0.459560:0.769070:0.459560:0.745246:0.264862:0.745246:0.010816:0.018547:0.012346:0.007730:0.018519:0.007730:0.015460:0.018547:0.015460:0.018547:0.027806:0.015460:0.007730
3:@0.459562:0.760618:0.468575:0.760618:0.468575:0.746729:0.459562:0.746729:0.009013
Spersatan:@0.539444:0.427144:0.752398:0.427144:0.752398:0.390660:0.539444:0.390660:0.023676:0.028402:0.026018:0.018907:0.021291:0.023676:0.018907:0.023676:0.028402
®:@0.754185:0.413011:0.767811:0.413011:0.767811:0.398417:0.754185:0.398417:0.013626
Latanoprost 50 µg/ml:@0.571510:0.446040:0.750852:0.446040:0.750852:0.431551:0.571510:0.431551:0.008186:0.009045:0.007343:0.009045:0.010746:0.010746:0.010746:0.007190:0.010746:0.008186:0.007343:0.005641:0.009903:0.009903:0.005641:0.010746:0.010746:0.008186:0.015851:0.003403
*:@0.755035:0.437287:0.766638:0.437287:0.766638:0.406971:0.755035:0.406971:0.011603
36465 Spersatan ad MIMMS full page.indd   1:@0.024391:1.028311:0.231495:1.028311:0.231495:1.019704:0.024391:1.019704:0.005660:0.005660:0.005660:0.005660:0.005660:0.002830:0.006790:0.005660:0.005660:0.003390:0.005090:0.005660:0.002830:0.005660:0.005660:0.002830:0.005660:0.005660:0.002830:0.008480:0.002830:0.008480:0.008480:0.006790:0.002830:0.002830:0.005660:0.002260:0.002260:0.002830:0.005660:0.005660:0.005660:0.005660:0.002830:0.002260:0.005660:0.005660:0.005660:0.002830:0.002830:0.002830:0.005660
2019/05/22   13:26:@0.925801:1.028311:1.010704:1.028311:1.010704:1.019704:0.925801:1.019704:0.005660:0.005660:0.005660:0.005660:0.002830:0.005660:0.005660:0.002830:0.005660:0.005660:0.002830:0.002830:0.002830:0.005660:0.005660:0.002830:0.005660:0.005660